Huaheng Biology (688639.SH) has announced its plans to issue H shares and seek listing on the Main Board of the Hong Kong Stock Exchange. This strategic move aims to propel the company's globalization efforts and further enhance its brand influence and core competitiveness. The proposal is contingent upon approval from the shareholders' general meeting.